Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 100Recruiting 42Unknown 23Terminated 23Active not recruiting 22Withdrawn 5Not yet recruiting 5Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 2Sarcoma 1Other solid neoplasm 1Other 1Head & Neck 1CNS 1Breast 1

Conditions

Head and Neck Neoplasms 11Squamous Cell Carcinoma of Head and Neck 6Thyroid Neoplasms 5Thyroid Nodule 3Thyroid Diseases 3Parathyroid Neoplasms 3Neoplasms 3Epilepsy 3Stress Disorders, Post-Traumatic 2Parkinson Disease 2Ovarian Neoplasms 2Hyperthyroidism 2Diabetes Mellitus 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Amyotrophic Lateral Sclerosis 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1Vitamin A Deficiency 1VLCAD deficiency 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Esophageal Neoplasms × Head & Neck × Clear all
NCT06690216 2025-03-30

PD-L1-PET

Shandong Cancer Hospital and Institute

Phase 1/2 Enrolling by invitation
100 enrolled
CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡